---
figid: PMC4426221__nihms667013f2
figtitle: Schematic summary graph shows the postsynaptic effects of mGluR2/3 agonists
  on the regulation of both AMPA and NMDA receptors
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Dryobalanops aromatica
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4426221
filename: nihms667013f2.jpg
figlink: /pmc/articles/PMC4426221/figure/F2/
number: F2
caption: A schematic summary graph shows the postsynaptic effects of mGluR2/3 agonists
  on the regulation of both AMPA and NMDA receptors. The mGluR2/3 agonist APDC significantly
  increases PKC-mediated phosphorylation of NMDA receptors (). APDC also increases
  the interaction between Rab4 and syntaxin 4, which facilitates the formation of
  soluble SNARE complexes that is composed of SNAP-25, syntaxin 4 and VAMP at postsynaptic
  sites, leading to the increased exocytosis of NMDARs (). Moreover, activation of
  mGluR2/3 inhibits the AC-cAMP-PKA pathway and thereby activates Src-mediated upregulation
  of NMDAR functions (). In addition, LY379268 increases the surface expression of
  AMPA receptors through activating ERK1/2 and GSK-3β signaling pathways (), directly
  modulates NMDAR expression and function, as well as reverses MK801-induced NMDAR
  dysfunction via activation of Akt/Gsk-3β pathway ().
papertitle: 'Perspectives on the mGluR2/3 agonists as a therapeutic target for schizophrenia:
  still promising or a dead end?.'
reftext: Meng-Lin Li, et al. Prog Neuropsychopharmacol Biol Psychiatry. ;60:66-76.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9791088
figid_alias: PMC4426221__F2
figtype: Figure
redirect_from: /figures/PMC4426221__F2
ndex: 2d0e8c42-debb-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4426221__nihms667013f2.html
  '@type': Dataset
  description: A schematic summary graph shows the postsynaptic effects of mGluR2/3
    agonists on the regulation of both AMPA and NMDA receptors. The mGluR2/3 agonist
    APDC significantly increases PKC-mediated phosphorylation of NMDA receptors ().
    APDC also increases the interaction between Rab4 and syntaxin 4, which facilitates
    the formation of soluble SNARE complexes that is composed of SNAP-25, syntaxin
    4 and VAMP at postsynaptic sites, leading to the increased exocytosis of NMDARs
    (). Moreover, activation of mGluR2/3 inhibits the AC-cAMP-PKA pathway and thereby
    activates Src-mediated upregulation of NMDAR functions (). In addition, LY379268
    increases the surface expression of AMPA receptors through activating ERK1/2 and
    GSK-3β signaling pathways (), directly modulates NMDAR expression and function,
    as well as reverses MK801-induced NMDAR dysfunction via activation of Akt/Gsk-3β
    pathway ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GRM2
  - GRIN1
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN3A
  - GRIN3B
  - GRM3
  - SNAP25
  - SNAR-E
  - RAB4A
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - CSK
  - AKT1
  - AKT2
  - AKT3
  - SRC
  - FGR
  - FYN
  - YES1
  - GSK3B
  - TRNA
  - Grm2
  - Grm3
  - Snap25
  - Rab4a
  - Prkcg
  - Csk
  - Akt1
  - Src
  - Gsk3b
  - Trna
  - Grin1
  - Napb
  - Vti1b
  - Gosr2
  - Napg
  - Napa
  - ac
  - TrnA
  - Nmdar2
  - Nmdar1
  - ee
  - Rab4
  - Syb
  - nSyb
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - costakink
  - Akt
  - Src42A
  - Src64B
  - sgg
  - gskt
  - trnA
  - tRNA:Asp-GTC-1-9
  - Syx1A
  - Ser
  - Cancer
---
